Tactile Medical to Release Third Quarter of Fiscal Year 2024 Financial Results on November 4, 2024
Tactile Systems Technology, Inc. (Nasdaq: TCMD), operating as Tactile Medical, has announced the release date for its third quarter fiscal year 2024 financial results. The results will be disclosed after market close on Monday, November 4, 2024. Following the release, management will host a conference call with a Q&A session at 5:00 p.m. Eastern Time on the same day.
Interested participants can dial 877-407-3088 (201-389-0927 for international callers) and use the access code 13748661. A live webcast will be available on the company's investor relations website. For those unable to attend, a replay will be accessible for two weeks.
Tactile Medical specializes in at-home therapies for chronic conditions such as lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease, aiming to improve patients' quality of life and reduce overall healthcare costs.
Tactile Systems Technology, Inc. (Nasdaq: TCMD), operante come Tactile Medical, ha annunciato la data di rilascio dei suoi risultati finanziari per il terzo trimestre dell'anno fiscale 2024. I risultati saranno divulgati dopo la chiusura del mercato lunedì 4 novembre 2024. Dopo il rilascio, la direzione ospiterà una telefonata di conferenza con una sessione di domande e risposte alle 17:00 ora orientale dello stesso giorno.
I partecipanti interessati possono comporre il numero 877-407-3088 (201-389-0927 per chiamate internazionali) e utilizzare il codice di accesso 13748661. Una trasmissione in diretta sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda. Per coloro che non possono partecipare, una registrazione sarà accessibile per due settimane.
Tactile Medical si specializza in terapie domiciliari per condizioni croniche come linfedema, lipedema, insufficienza venosa cronica e malattia polmonare cronica, con l'obiettivo di migliorare la qualità della vita dei pazienti e ridurre i costi complessivi dell'assistenza sanitaria.
Tactile Systems Technology, Inc. (Nasdaq: TCMD), que opera como Tactile Medical, ha anunciado la fecha de publicación de sus resultados financieros del tercer trimestre del año fiscal 2024. Los resultados se darán a conocer después del cierre del mercado el lunes 4 de noviembre de 2024. Después de la divulgación, la dirección llevará a cabo una llamada de conferencia con una sesión de preguntas y respuestas a las 5:00 p.m. hora del este del mismo día.
Los participantes interesados pueden marcar el 877-407-3088 (201-389-0927 para llamadas internacionales) y usar el código de acceso 13748661. Una transmisión en vivo estará disponible en el sitio web de relaciones con inversores de la empresa. Para aquellos que no puedan asistir, se podrá acceder a una repetición durante dos semanas.
Tactile Medical se especializa en terapias en casa para condiciones crónicas como linfedema, lipedema, insuficiencia venosa crónica y enfermedad pulmonar crónica, con el objetivo de mejorar la calidad de vida de los pacientes y reducir los costos generales de atención médica.
Tactile Systems Technology, Inc. (Nasdaq: TCMD), Tactile Medical으로 운영되는 이 회사는 2024 회계연도 3분기 재무 결과 발표일을 발표했습니다. 결과는 2024년 11월 4일 월요일, 시장 마감 후에 공개됩니다. 공개 후, 경영진은 같은 날 동부 표준시 오후 5시에 질문 및 답변 세션이 있는 컨퍼런스 콜을 진행합니다.
참여를 원하는 분은 877-407-3088 (국제 전화는 201-389-0927)로 전화하시고 접속 코드 13748661을 사용하면 됩니다. 회사의 투자자 관계 웹사이트에서 실시간 웹캐스트를 이용할 수 있습니다. 참석할 수 없는 분들을 위해 2주 동안 재생 가능하도록 할 예정입니다.
Tactile Medical은 만성 질환에 대한 집에서 할 수 있는 치료법을 전문으로 하며, 림프부종, 지방부종, 만성 정맥 기능 부전, 만성 폐 질환을 포함하여 환자의 삶의 질을 향상시키고 전체 의료 비용을 줄이는 것을 목표로 합니다.
Tactile Systems Technology, Inc. (Nasdaq: TCMD), opérant sous le nom de Tactile Medical, a annoncé la date de publication de ses résultats financiers du troisième trimestre de l'exercice 2024. Les résultats seront divulgués après la fermeture du marché le lundi 4 novembre 2024. Suite à la publication, la direction animera une conférence téléphonique avec une session de questions-réponses à 17h00, heure de l'Est le même jour.
Les participants intéressés peuvent composer le 877-407-3088 (201-389-0927 pour les appelants internationaux) et utiliser le code d'accès 13748661. Une diffusion en direct sera disponible sur le site Web des relations avec les investisseurs de l'entreprise. Pour ceux qui ne peuvent pas assister, un replay sera accessible pendant deux semaines.
Tactile Medical se spécialise dans les thérapies à domicile pour les maladies chroniques telles que le lymphœdème, le lipœdème, l'insuffisance veineuse chronique, et les maladies pulmonaires chroniques, visant à améliorer la qualité de vie des patients et à réduire les coûts globaux des soins de santé.
Tactile Systems Technology, Inc. (Nasdaq: TCMD), das als Tactile Medical tätig ist, hat das Veröffentlichungsdatum seiner finanziellen Ergebnisse für das dritte Quartal des Geschäftsjahres 2024 bekannt gegeben. Die Ergebnisse werden nach Marktschluss am Montag, den 4. November 2024 veröffentlicht. Nach der Bekanntgabe wird das Management um 17:00 Uhr Eastern Time am selben Tag eine Konferenzschaltung mit einer Frage-und-Antwort-Sitzung abhalten.
Interessierte Teilnehmer können die Nummer 877-407-3088 (201-389-0927 für internationale Anrufer) wählen und den Zugangscode 13748661 verwenden. Eine Live-Webcast wird auf der Investor-Relations-Website des Unternehmens verfügbar sein. Für diejenigen, die nicht teilnehmen können, wird eine Wiederholung für zwei Wochen verfügbar sein.
Tactile Medical spezialisiert sich auf Therapien zu Hause für chronische Erkrankungen wie Lymphödem, Lipödem, chronische venöse Insuffizienz und chronische Lungenerkrankungen, mit dem Ziel, die Lebensqualität der Patienten zu verbessern und die Gesamtkosten im Gesundheitswesen zu senken.
- Timely disclosure of quarterly financial results
- Provision of conference call and webcast for investor engagement
- Offering of replay options for increased accessibility to financial information
- None.
MINNEAPOLIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that third quarter of fiscal year 2024 financial results will be released after the market closes on Monday, November 4, 2024.
Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on November 4, 2024, to discuss the results of the quarter. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13748661. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.
For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13748661. The webcast will be archived at investors.tactilemedical.com.
About Tactile Systems Technology, Inc. (DBA Tactile Medical)
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com
FAQ
When will Tactile Medical (TCMD) release its Q3 2024 financial results?
How can investors participate in Tactile Medical's (TCMD) Q3 2024 earnings call?
What time is Tactile Medical's (TCMD) Q3 2024 earnings conference call scheduled for?
What chronic conditions does Tactile Medical (TCMD) develop therapies for?
